Patent Assignment
Reel/Frame 068469/0001
Security Interest
Recorded: 2024-07-22
Pages: 29
Assignee
COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
1505 ENERGY PARK DRIVE, ATTENTION: CORPORATE TRUST SERVICES – ENDO FINANCE HOLDINGS, INC. ADMINISTRATOR, ST. PAUL, MINNESOTA, 55108
Covered Properties
(159)
Pelvic Disorder Treatment Device
Sustained Release Formulations of Metformin
Surgical Article and Methods for Treating Female Urinary Incontinence
Process for the Preparation of Amphiphilic Poly (N-Vinyl-2-Pyrrolidone) Block Copolymers
Handle and Surgical Article
Non-Surgical Incontinence Treatment System and Method
Electrically Heated/Phase Change Probe Temperature Control
Heating Method for Tissue Contraction
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Patent:
7,229,636 →
Application:
10/787,385 →
Incontinence Treatment with Urethral Guide
Prolapse Repair
Nasal Calcitonin Formulations Containing Chlorobutanol
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Patent:
7,404,489 →
Application:
10/814,399 →
Method and Apparatus for Treating Pelvic Organ Prolapse
Method and Apparatus for Cystocele Repair
Delayed Release Dosage Forms
Endo-Pelvic Fascia Penetrating Heating Systems and Methods for Incontinence Treatment
Heating Method for Tissue Contraction
Controlled-release compositions
Sustained-Release Tramadol Formulations with 24-Hour Efficacy
Surgical Implants and Related Methods
Compositions and Methods for Treating Precocious Puberty
Method for Supporting Vaginal Cuff
Transobturator Surgical Articles and Methods
Ultrapure 4-Methylpyrazole
Controlled Release Formulations of Octreotide
Apparatus for Treating Stress and Urge Incontinence
Oxymorphone Controlled Release Formulations
Sustained release formulations of nalbuphine
Method of Inserting an Object Under the Skin
Oxymorphone Controlled Release Formulations
Compositions and Methods for Treating Collagen-Mediated Diseases
Pelvic Floor Implant System and Method of Assembly
Methods and Systems for Treatment of Prolapse
Prolapse Repair
Method and Apparatus for Cystocele Repair
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Multi-Leveled Transgluteal Tension-Free Levatorplasty for Treatment of Rectocele
Implant Device Release Agents and Methods of Using Same
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Sustained Release Formulations of Nalbuphine
Delivery of Dry Formulations of Octreotide
Controlled Release Formulations of Octreotide
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
Electrode Sling for Treating Stress and Urge Incontinence
Method and Apparatus for Treating Pelvic Organ Prolapse
Misuse Preventative, Controlled Release Formulation
Combination Treatment for Bladder Cancer
Method and Apparatus for Prolapse Repair
An Implantable Device for the Sustained Release of a Polypeptide
Octreotide Implant Having a Release Agent and Uses Thereof
Kit For Levator Avulsion Repair
Vitamin B12 Nasal Spray and Method of Use
Misuse Preventative, Controlled Release Formulation
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Controlled Release Formulations of Octreotide
A Method of Manufacturing an Implantable Device
Nasal Calcitonin Formulations Containing Chlorobutanol
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Method for Supporting Vaginal Cuff
Octreotide Implant Having a Release Agent
Narcotic Drug Formulations with Decreased Abuse Potential
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Prolapse Repair
Nasal Calcitonin Formulations Containing Chlorobutanol
Compositions and Methods for Producing Clostridial Collagenases
Apparatus and Method for Repairing Vaginal Reconstruction
Sustained Release Formulation of Nalbuphine
Method of Manufacturing an Implantable Device
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Methods and Systems for Treatment of Prolapse
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Method for Supporting Vaginal Cuff
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Treatment Method and Product for Uterine Fibroids using Purified Collagenase
Treatment Method and Product for Uterine Fibroids Using Purified Collagenase
Sustained Release Formulation of Nalbuphine
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Prolapse Repair
Sustained Release Formulation of Nalbuphine
Clostridium Histolyticum Enzymes and Methods for the Use Thereof
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Epinephrine Formulations
Patent:
9,119,876 →
Application:
14/657,990 →
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Patent:
9,375,478 →
Application:
14/717,882 →
Vitamin B12 Nasal Spray and Method of Use
Methods and Systems for Treatment of Prolapse
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Epinephrine Formulations
Patent:
9,295,657 →
Application:
14/818,121 →
Epinephrine Formulations
Vitamin B12 Nasal Spray and Method of Use
Systems and Methods for Treating a Pelvic Disorder
Thermosensitive Hydrogel Collagenase Formulations
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Sustained Release Formulation of Nalbuphine
Clostridium Histolyticum Enzymes and Methods for the Use Thereof
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Solid Formulations of Liquid Biologically Active Agents
Sustained Release Formulations of Nalbuphine
Systems and Methods for Treating a Pelvic Disorder
Epinephrine Formulations
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Nucleic Acid Molecules Encoding Clostridium Histolyticum Collagenase I and Methods of Producing the Same
Epinephrine Formulations
Pre-Filled Syringe Containing Sugammadex
Patent:
11,097,023 →
Application:
16/919,790 →
Compositions and Methods for Producing Clostridial Collagenases
Application:
17/004,857 →
Publication:
US 2021/0040468
Treatment Method and Product for Uterine Fibroids using Purified Collagenase
Application:
17/064,126 →
Publication:
US 2021/0023014
Treatment of Uterine Fibroids using Purified Collagenase
Thermosensitive Hydrogel Collagenase Formulations
Application:
17/083,650 →
Publication:
US 2021/0060143
Peptide Congeners with Polymer Excipients
Application:
17/104,102 →
Publication:
US 2021/0077568
Implantable Device for the Delivery of Octreotide and Methods of Use Thereof
Application:
17/172,821 →
Publication:
US 2021/0161994
Treatment Method and Product for Uterine Fibroids using Purified Collagenase
Injection Techniques for the Treatment of Cellulite
Application:
17/259,784 →
Publication:
US 2021/0187084
Compositions and Methods for Treating Cellulite
Application:
17/276,507 →
Publication:
US 2024/0277595
Collagenase Formulations and Methods of Producing the Same
Application:
17/419,899 →
Publication:
US 2022/0305094
Vasopressin Formulations for Use in Treatment of Hypotension
Epinephrine Formulations
Epinephrine Formulations
Application:
17/694,165 →
Publication:
US 2023/0285326
Varenicline Compound and Process of Manufacture Thereof
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Application:
17/838,636 →
Publication:
US 2022/0313688
Vasopressin Formulations for Use in Treatment of Hypotension
Application:
17/861,353 →
Publication:
US 2023/0256048
Varenicline Compound and Process of Manufacture Thereof
Patent:
11,717,524 →
Application:
17/930,824 →
Varenicline Compound and Process of Manufacture Thereof
Application:
17/930,940 →
Publication:
US 2023/0285404
Compositions and Methods for Treating Collagen-Mediated Diseases
Application:
17/932,230 →
Publication:
US 2023/0158127
Vareniciline Compound and Process of Manufacture Thereof
Controlled Release Formulations of Octreotide
Application:
18/230,990 →
Delivery of Dry Formulations of Octreotide
Application:
18/237,644 →
Varenicline Compound and Process of Manufacture Thereof
Array Substrate and Liquid Crystal Display Device
Nucleic Acids Encoding Clostridium Histolyticum Delta Toxin and Methods of Producing the Same
Application:
18/329,308 →
Publication:
US 2024/0252602
Nucleic Acid Molecules Encoding Clostridium Histolyticum Collagenase Ii and Methods of Producing the Same
Method of Treating or Reducing Efp
Application:
18/415,270 →
Publication:
US 2024/0216485
Compositions and Methods for Treating Precocious Puberty
Application:
18/419,099 →
Controlled Release Formulations of Octreotide
Application:
18/422,859 →
Delivery of Dry Formulations of Octreotide
Application:
18/428,462 →
Epinephrine Formulations
Application:
18/470,256 →
Publication:
US 2024/0091176
Epinephrine Formulations
Treatment Method and Product for Uterine Fibroids using Purified Collagenase
Application:
18/513,988 →
Publication:
US 2024/0082164
Treatment Of Uterine Fibroids Using Purified Collagenase
Application:
18/530,981 →
Publication:
US 2024/0165211
Nucleic Acid Molecules Encoding Clostridium Histolyticum Collagenase I and Methods of Producing the Same
Application:
18/615,520 →
Publication:
US 2024/0269245
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 4, 2004
From: MELLIER, GEORGES
To: AMS RESEARCH CORPORATION
Reel/Frame 015850/0848 →
Security Agreement
Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
Grant of Security Interest in Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Release of Security Interest
Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0318 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
Change of Name
Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0354 →
Assignment of Assignor's Interest
Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
Change of Name
Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
Change of Name
Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
Assignment of Assignor's Interest
Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0260 →
Corrective Assignment to Correct the Conveying Party Name Previously Recorded at Reel: 037300 Frame: 0607. Assignor(S) Hereby Confirms the Assignment.
Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
Assignment of Assignor's Interest
Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
Change of Name
Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
Assignment of Assignor's Interest
Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
Corrective Assignment to Correct the Conveying Party Data; Previously Recorded on Reel 037300 Frame 0199. Assignor(S) Hereby Confirms the Change of Name.
Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
Corrective Assignment to Correct the Assignor Name Previously Recorded at Reel: 037300 Frame: 0318. Assignor(S) Hereby Confirms the Change of Name.
Sep 6, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 039919/0017 →
Corrective Assignment to Correct the Conveying Party Data Name Previously Recorded at Reel: 037300 Frame: 0728. Assignor(S) Hereby Confirms the Change of Name.
Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
Release of Security Interest
Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: PAR PHARMACEUTICAL, INC.; ENDO GENERICS HOLDINGS, INC.; INNOTEQ, INC.
Reel/Frame 042171/0036 →
Release of Security Interest
Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
Security Interest
Jun 8, 2017
From: PAR PHARMACEUTICAL, INC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0216 →
Security Interest
Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →